The Mookherjee Lab:
at The Manitoba Center for Proteomics &
Systems Biology
Dr. Neeloffer Mookherjee - Principal Investigator
Professor, Departments of Internal Medicine and Immunology
CIHR Sex and Gender Science Chair - Circulatory & Respiratory Health
@NMfromUManitoba
The Mookherjee lab is an inclusive environment, committed to Equity, Diversity and Inclusion.
Dr. Mookherjee is committed to ensuring that everyone is given opportunities to excel in their scholarly activities.
Dr. Mookherjee is current Chair of WISDOM (Women In Science: Development, Outreach & Mentoring)
A Rady Faculty of Health Sciences instituted initiative at The University of Manitoba
RESEARCH PROGRAM VISION
To advance the fundamental understanding of Molecular Processes in Chronic Inflammation, and harness the Biology of Cationic Host Defence Peptides to develop immunomodulatory therapy for chronic disease.
Dr. Mookherjee is at the forefront of defining the immunity related functions of cationic host defence (antimicrobial) peptides, and the development of small-peptide based therapeutics for chronic inflammatory diseases.
Dr. Mookherjee's current role as a CIHR Sex and Gender Science Chair – Circulatory and Respiratory Health expands the scope of her research program to integrate the impact of sex as a biological variable on respiratory disease progression and response to therapy.
Research Focus:
-
To define molecular processes in the regulation of inflammation, including biological sex-related differences, in chronic inflammatory disease, with focus on asthma and arthritis.
-
To examine immunity related functions, including regulation of inflammation, by Cationic Host Defence Peptides (also known as antimicrobial peptides).
-
To investigate the role of Cationic Host Defence Peptides in inflammatory disease such as asthma and arthritis.
-
To develop small synthetic derivatives of host defence peptides, known as Innate Defence Regulator (IDR) Peptides, as immunomodulatory therapy for asthma and arthritis.
-
To investigate impact of environmental pollutants of the lung and plasma proteome, in the context of chronic respiratory disease such as asthma.
Ongoing Funded Projects (link to project details).